APA (7th ed.) Citation

M, L., A, L., A, C., C, B., J, K., B, J., . . . ZI, M. (2021). Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies. NPJ precision oncology, 5(1), 92. https://doi.org/10.1038/s41698-021-00232-w

Chicago Style (17th ed.) Citation

M, Labrie, et al. "Multiomics Analysis of Serial PARP Inhibitor Treated Metastatic TNBC Inform on Rational Combination Therapies." NPJ Precision Oncology 5, no. 1 (2021): 92. https://doi.org/10.1038/s41698-021-00232-w.

MLA (9th ed.) Citation

M, Labrie, et al. "Multiomics Analysis of Serial PARP Inhibitor Treated Metastatic TNBC Inform on Rational Combination Therapies." NPJ Precision Oncology, vol. 5, no. 1, 2021, p. 92, https://doi.org/10.1038/s41698-021-00232-w.